Bridge City Capital »

Catalyst Pharmaceutical Partners shares owned by Bridge City Capital

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Bridge City Capital from 13F filings

Historical chart of Bridge City Capital investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Bridge City Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Bridge City Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.6M 182k 19.70
2025-06-30 $2.5M 116k 21.70
2025-03-31 $2.8M 117k 24.25

More positions owned by Bridge City Capital

Ensign (ENSG)
Sterling Construction Company (STRL)
Glacier Ban (GBCI)
Pacira Pharmaceuticals (PCRX)
Dorman Products (DORM)
A10 Networks (ATEN)
RBC Bearings Incorporated (RBC)
Harmony Biosciences Hldgs In (HRMY)
Fabrinet (FN)
OSI Systems (OSIS)
Modine Manufacturing (MOD)
Lithia Motors (LAD)
Globus Med Inc cl a (GMED)
ACI Worldwide (ACIW)
LeMaitre Vascular (LMAT)

View all positions for Bridge City Capital

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Morgan Stanley
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners